2014 Immunisation Schedule
A schedule update from PHARMAC has been issued for implementation by 01 July 2014.
The National Immunisation Register has been updated as a result of the 2014 schedule changes (see Below for a summary of these changes).
Changes have been made to MyPractice to support changes to the Immunisation schedules and NIR requirements as requested by the Ministry of Health.
Most of these changes will take effect once the 14.6 or later updates are installed
The vaccine groups will also be updated with the correct vaccines for the 6 week, 3 months, 5 months, 15 months, 4 Year and 11 Year schedules except the PCV13 vaccine.
A change from the PCV10 to the PCV13 pneumococcal vaccine will require manual updating as this is dependent on when your PCV10 stocks are depleted and replaced with the new PCV13 vaccines. Please call the helpdesk if assistance is required for this step.
Instructions for vaccinators
Apart from updating the vaccine group, no change in how vaccines are scheduled or recorded is required by users.
Routine Childhood vaccines
When the appropriate vaccine group is selected e.g. 3M, the appropriate new vaccines will be presented. Enter /update details as before .
New funded vaccines
Some vaccines will require the new indication of Standard to be selected (for eligible patients) in order to make a claim.
Vaccines to be sent to NIR
If vaccines need to be sent to the NIR the message status will default to Send
2014 Immunisation Schedule Change
On 1 July 2014 the following changes were made to the National Immunisation Schedule.
All children transfer to the new Schedule from 1 July 2014, although the date the new vaccines are available may be later than 1 July while existing vaccine stocks are used up. There are no changes to the ages of the routine immunisation events.
Key Changes to the National Immunisation Schedule from 1 July 2014
|Vaccine||Brand Name||Scheduled event||Route||New/Replaces|
|1||Rotavirus vaccine (RV5)||RotaTeq||6 weeks, 3 & 5 months||Oral||New on schedule|
|2||13-valent pneumococcal vaccine (PCV13)||Prevenar 13||6 weeks, 3, 5, & 15 months||IM||Replaces: 10-valent pneumococcal conjugate vaccine (PCV10, Synflorix) event at 6 weeks, 3, 5 and 15 months|
|3.||DTaP-IPV (paediatric diphtheria, tetanus, acellular pertussis and polio vaccine)
|4.|| Tdap (adult tetanus, diphtheria and acellular pertussis vaccine)
|5.||DTaP-IPV-Hep B/Hib has been confirmed as a catch-up option for children aged 5 to under 7 years.|
|6.||Funded quadrivalent human papillomavirus vaccine (HPV4, Gardasil)
|7.||All vaccines on the Schedule are funded for revaccination following immunosuppression|
|8.||Serology testing for babies of HBsAg-positive mothers:
|9.||Women with rubella antibody levels of<10 IU/ml are considered to be non-immune to rubella. This is a change from the previous recommendation of <15 IU/ml.|
|10.|| The following vaccines have been funded for special groups (ie children and adults at high risk of some diseases due to other medical conditions):